Search

Acetic acid versus toluidine blue as screening tools for oral potentially malignant disorders

메타 데이터

바이오화학분류
    • 바이오정밀화학
      1. 용매
    • 화장품용 기능성소재
      1. 계면활성제⁄증점제
    • 의료용 화학소재
      1. 식품첨가제
논문

Acetic acid versus toluidine blue as screening tools for oral potentially malignant disorders

학술지

Indian journal of cancer

저자명

Winton Kalluvelil, San Rose; Narayanan, Veena S.

초록

<P>Background:<P>Diagnostic adjuncts such as toluidine blue have been investigated as screening tools that improve visual examination of potentially malignant disorders (PMD) and oral cancer. Acetic acid has been reported to be of value in the early detection of cervical cancers. This study assessed the utility of 5% acetic acid as a diagnostic adjunct in oral PMD and compared the accuracy of acetic acid with toluidine blue in the detection of dysplastic PMD and high-risk lesions.</P></P><P>Materials and Methods:<P>This cross-sectional study was conducted at a dental hospital in a rural setting. Thirty-one patients with oral PMD formed the study group. Five percent acetic acid was applied to the lesions, followed by toluidine blue application and biopsy. Sensitivity, specificity, and positive and negative predictive values were computed considering true positives as stain uptake in dysplastic and high-risk PMD.</P></P><P>Results:<P>The sensitivity, specificity, and positive and negative predictive values of acetic acid for identifying dysplastic or malignant lesions were 100%, 13.3%, 51.2%, and 100%, respectively, and that for toluidine blue were 75%, 100%, 100%, and 78.9%, respectively. The corresponding values for identifying high-risk PMD (lesions with moderate and severe dysplasia) using acetic acid were 100%, 9.1%, 25.9%, and 100%, respectively, and for toluidine blue were 85.7%, 81.8%, 60%, and 94.7%, respectively.</P></P><P>Conclusion:<P>The utility of acetic acid in detecting dysplasia and high-risk PMD is severely limited due to its poor specificity. Compared with acetic acid, toluidine blue is a superior screening tool.</P></P>

발행연도

2023

발행기관

Medknow Publications

ISSN

0019-509x

ISSN

1998-4774

60

3

페이지

pp.427-431

0건의 논문이 있습니다.

0건의 특허가 있습니다.

0건의 무역이 있습니다.

1건의 후보군 물질이 있습니다.

1 2023-12-11

논문; 2023-07-01

Export

About

Search

Trend